Kotaro Nomura
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
ASO Visual Abstract: Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung Cancer.
Journal: Annals of surgical oncology
Published: June 20, 2026
Real-world outcomes of unresected non-small cell lung cancer following neoadjuvant chemoimmunotherapy.
Journal: General thoracic and cardiovascular surgery
Published: April 17, 2026
Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).
Journal: Annals of surgical oncology
Published: March 25, 2026
Clinical predictors of pathological response after immunotherapy in salvage surgery for non-small cell lung cancer: a supplementary analysis of the CReGYT-05 immune checkpoint inhibitor-salvage study.
Journal: General thoracic and cardiovascular surgery
Published: February 25, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 18, 2025
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.
Journal: Annals of surgical oncology
Published: December 17, 2025
Brief Report: Low Delta-Like Ligand 3 Expression and T-Cell Exhaustion Drive Resistance to Tarlatamab Combined With Anti-Programmed Cell Death Protein 1 in SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 03, 2025
Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer.
Journal: Annals of surgical oncology
Published: December 03, 2025
Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 14, 2025
Preoperative Immune-Related Adverse Events in Resectable NSCLC Treated With Neoadjuvant Nivolumab Plus Chemotherapy: A Multicenter Retrospective Analysis.
Journal: JTO clinical and research reports
Published: August 21, 2025
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness.
Journal: British journal of cancer
Published: August 14, 2025
Last Updated: 09/26/2026